nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—CHRFAM7A—corpus luteum—breast cancer	0.104	0.373	CbGeAlD
Butabarbital—CHRNA7—corpus luteum—breast cancer	0.0838	0.301	CbGeAlD
Butabarbital—GRIA2—embryo—breast cancer	0.012	0.0433	CbGeAlD
Butabarbital—CHRNA7—skin of body—breast cancer	0.00688	0.0247	CbGeAlD
Butabarbital—CHRFAM7A—female reproductive system—breast cancer	0.00666	0.0239	CbGeAlD
Butabarbital—GRIA2—endocrine gland—breast cancer	0.00618	0.0222	CbGeAlD
Butabarbital—CHRFAM7A—female gonad—breast cancer	0.00606	0.0218	CbGeAlD
Butabarbital—CHRNA7—uterus—breast cancer	0.00598	0.0215	CbGeAlD
Butabarbital—GABRG2—pituitary gland—breast cancer	0.00567	0.0204	CbGeAlD
Butabarbital—CHRFAM7A—endocrine gland—breast cancer	0.00563	0.0203	CbGeAlD
Butabarbital—GRIK2—endocrine gland—breast cancer	0.00558	0.0201	CbGeAlD
Butabarbital—CHRNA7—female reproductive system—breast cancer	0.00537	0.0193	CbGeAlD
Butabarbital—CHRNA7—adrenal gland—breast cancer	0.00525	0.0189	CbGeAlD
Butabarbital—CHRNA4—adrenal gland—breast cancer	0.00517	0.0186	CbGeAlD
Butabarbital—CHRNA7—female gonad—breast cancer	0.00489	0.0176	CbGeAlD
Butabarbital—CHRNA7—endocrine gland—breast cancer	0.00455	0.0164	CbGeAlD
Butabarbital—CHRNA4—endocrine gland—breast cancer	0.00449	0.0161	CbGeAlD
Butabarbital—Rash—Letrozole—breast cancer	0.0018	0.00282	CcSEcCtD
Butabarbital—Rash—Anastrozole—breast cancer	0.0018	0.00282	CcSEcCtD
Butabarbital—Dermatitis—Letrozole—breast cancer	0.0018	0.00282	CcSEcCtD
Butabarbital—Dermatitis—Anastrozole—breast cancer	0.0018	0.00282	CcSEcCtD
Butabarbital—Agitation—Thiotepa—breast cancer	0.0018	0.00281	CcSEcCtD
Butabarbital—Dizziness—Raloxifene—breast cancer	0.00179	0.00281	CcSEcCtD
Butabarbital—Headache—Letrozole—breast cancer	0.00179	0.0028	CcSEcCtD
Butabarbital—Headache—Anastrozole—breast cancer	0.00179	0.0028	CcSEcCtD
Butabarbital—Hypotension—Melphalan—breast cancer	0.00179	0.0028	CcSEcCtD
Butabarbital—Ataxia—Capecitabine—breast cancer	0.00177	0.00276	CcSEcCtD
Butabarbital—Hypotension—Goserelin—breast cancer	0.00175	0.00273	CcSEcCtD
Butabarbital—Body temperature increased—Chlorambucil—breast cancer	0.00174	0.00272	CcSEcCtD
Butabarbital—Vomiting—Raloxifene—breast cancer	0.00173	0.0027	CcSEcCtD
Butabarbital—Vomiting—Idarubicin—breast cancer	0.00173	0.0027	CcSEcCtD
Butabarbital—Constipation—Vinblastine—breast cancer	0.00172	0.00269	CcSEcCtD
Butabarbital—Rash—Idarubicin—breast cancer	0.00171	0.00268	CcSEcCtD
Butabarbital—Rash—Raloxifene—breast cancer	0.00171	0.00268	CcSEcCtD
Butabarbital—Dermatitis—Raloxifene—breast cancer	0.00171	0.00267	CcSEcCtD
Butabarbital—Dermatitis—Idarubicin—breast cancer	0.00171	0.00267	CcSEcCtD
Butabarbital—Headache—Raloxifene—breast cancer	0.0017	0.00266	CcSEcCtD
Butabarbital—Headache—Idarubicin—breast cancer	0.0017	0.00266	CcSEcCtD
Butabarbital—Nausea—Letrozole—breast cancer	0.0017	0.00266	CcSEcCtD
Butabarbital—Nausea—Anastrozole—breast cancer	0.0017	0.00266	CcSEcCtD
Butabarbital—Phenobarbital—ABCC1—breast cancer	0.00168	0.291	CrCbGaD
Butabarbital—Constipation—Tamoxifen—breast cancer	0.00167	0.00262	CcSEcCtD
Butabarbital—Hepatocellular injury—Doxorubicin—breast cancer	0.00167	0.00261	CcSEcCtD
Butabarbital—Anxiety—Thiotepa—breast cancer	0.00166	0.0026	CcSEcCtD
Butabarbital—Somnolence—Goserelin—breast cancer	0.00166	0.0026	CcSEcCtD
Butabarbital—Feeling abnormal—Vinblastine—breast cancer	0.00166	0.0026	CcSEcCtD
Butabarbital—Hypersensitivity—Chlorambucil—breast cancer	0.00162	0.00253	CcSEcCtD
Butabarbital—Bradycardia—Paclitaxel—breast cancer	0.00161	0.00252	CcSEcCtD
Butabarbital—Nausea—Raloxifene—breast cancer	0.00161	0.00252	CcSEcCtD
Butabarbital—Nausea—Idarubicin—breast cancer	0.00161	0.00252	CcSEcCtD
Butabarbital—Confusional state—Thiotepa—breast cancer	0.00161	0.00252	CcSEcCtD
Butabarbital—Constipation—Goserelin—breast cancer	0.0016	0.0025	CcSEcCtD
Butabarbital—Hypotension—Vinorelbine—breast cancer	0.00156	0.00245	CcSEcCtD
Butabarbital—Feeling abnormal—Goserelin—breast cancer	0.00154	0.00241	CcSEcCtD
Butabarbital—Syncope—Irinotecan—breast cancer	0.00152	0.00237	CcSEcCtD
Butabarbital—Loss of consciousness—Irinotecan—breast cancer	0.00149	0.00232	CcSEcCtD
Butabarbital—Hypersensitivity—Vinblastine—breast cancer	0.00148	0.00232	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Methotrexate—breast cancer	0.00148	0.00232	CcSEcCtD
Butabarbital—Body temperature increased—Goserelin—breast cancer	0.00148	0.00231	CcSEcCtD
Butabarbital—Hypersensitivity—Tamoxifen—breast cancer	0.00144	0.00225	CcSEcCtD
Butabarbital—Anxiety—Mitoxantrone—breast cancer	0.00144	0.00224	CcSEcCtD
Butabarbital—Constipation—Vinorelbine—breast cancer	0.00143	0.00224	CcSEcCtD
Butabarbital—Somnolence—Thiotepa—breast cancer	0.00142	0.00222	CcSEcCtD
Butabarbital—Hypersensitivity—Melphalan—breast cancer	0.00141	0.00221	CcSEcCtD
Butabarbital—Vomiting—Chlorambucil—breast cancer	0.0014	0.00219	CcSEcCtD
Butabarbital—Confusional state—Irinotecan—breast cancer	0.00139	0.00218	CcSEcCtD
Butabarbital—Confusional state—Mitoxantrone—breast cancer	0.00139	0.00218	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Epirubicin—breast cancer	0.00139	0.00217	CcSEcCtD
Butabarbital—Feeling abnormal—Vinorelbine—breast cancer	0.00138	0.00216	CcSEcCtD
Butabarbital—Hypersensitivity—Goserelin—breast cancer	0.00138	0.00215	CcSEcCtD
Butabarbital—Constipation—Thiotepa—breast cancer	0.00137	0.00214	CcSEcCtD
Butabarbital—Shock—Irinotecan—breast cancer	0.00136	0.00212	CcSEcCtD
Butabarbital—Shock—Mitoxantrone—breast cancer	0.00136	0.00212	CcSEcCtD
Butabarbital—Tension—Paclitaxel—breast cancer	0.00135	0.00212	CcSEcCtD
Butabarbital—Nervousness—Paclitaxel—breast cancer	0.00134	0.0021	CcSEcCtD
Butabarbital—Confusional state—Fluorouracil—breast cancer	0.00133	0.00208	CcSEcCtD
Butabarbital—Dizziness—Vinblastine—breast cancer	0.00133	0.00208	CcSEcCtD
Butabarbital—Bradycardia—Capecitabine—breast cancer	0.00132	0.00207	CcSEcCtD
Butabarbital—Body temperature increased—Vinorelbine—breast cancer	0.00132	0.00207	CcSEcCtD
Butabarbital—Feeling abnormal—Thiotepa—breast cancer	0.00132	0.00206	CcSEcCtD
Butabarbital—Ataxia—Methotrexate—breast cancer	0.00132	0.00206	CcSEcCtD
Butabarbital—Nausea—Chlorambucil—breast cancer	0.00131	0.00204	CcSEcCtD
Butabarbital—Dizziness—Tamoxifen—breast cancer	0.00129	0.00202	CcSEcCtD
Butabarbital—Hypotension—Mitoxantrone—breast cancer	0.00129	0.00202	CcSEcCtD
Butabarbital—Hypotension—Irinotecan—breast cancer	0.00129	0.00202	CcSEcCtD
Butabarbital—Phenobarbital—CYP1B1—breast cancer	0.00129	0.222	CrCbGaD
Butabarbital—Dermatitis exfoliative—Doxorubicin—breast cancer	0.00128	0.00201	CcSEcCtD
Butabarbital—Vomiting—Vinblastine—breast cancer	0.00128	0.002	CcSEcCtD
Butabarbital—Agitation—Paclitaxel—breast cancer	0.00127	0.00198	CcSEcCtD
Butabarbital—Body temperature increased—Thiotepa—breast cancer	0.00126	0.00198	CcSEcCtD
Butabarbital—Headache—Vinblastine—breast cancer	0.00126	0.00197	CcSEcCtD
Butabarbital—Angioedema—Paclitaxel—breast cancer	0.00126	0.00197	CcSEcCtD
Butabarbital—Hypotension—Gemcitabine—breast cancer	0.00126	0.00196	CcSEcCtD
Butabarbital—Vomiting—Tamoxifen—breast cancer	0.00124	0.00195	CcSEcCtD
Butabarbital—Syncope—Paclitaxel—breast cancer	0.00124	0.00193	CcSEcCtD
Butabarbital—Dizziness—Goserelin—breast cancer	0.00124	0.00193	CcSEcCtD
Butabarbital—Hypotension—Fluorouracil—breast cancer	0.00124	0.00193	CcSEcCtD
Butabarbital—Rash—Tamoxifen—breast cancer	0.00123	0.00193	CcSEcCtD
Butabarbital—Hypersensitivity—Vinorelbine—breast cancer	0.00123	0.00193	CcSEcCtD
Butabarbital—Dermatitis—Tamoxifen—breast cancer	0.00123	0.00193	CcSEcCtD
Butabarbital—Ataxia—Epirubicin—breast cancer	0.00123	0.00193	CcSEcCtD
Butabarbital—Somnolence—Irinotecan—breast cancer	0.00123	0.00192	CcSEcCtD
Butabarbital—Somnolence—Mitoxantrone—breast cancer	0.00123	0.00192	CcSEcCtD
Butabarbital—Headache—Tamoxifen—breast cancer	0.00123	0.00192	CcSEcCtD
Butabarbital—Vomiting—Melphalan—breast cancer	0.00122	0.0019	CcSEcCtD
Butabarbital—Loss of consciousness—Paclitaxel—breast cancer	0.00121	0.0019	CcSEcCtD
Butabarbital—Rash—Melphalan—breast cancer	0.00121	0.00189	CcSEcCtD
Butabarbital—Dermatitis—Melphalan—breast cancer	0.00121	0.00189	CcSEcCtD
Butabarbital—Nausea—Vinblastine—breast cancer	0.0012	0.00187	CcSEcCtD
Butabarbital—Somnolence—Gemcitabine—breast cancer	0.0012	0.00187	CcSEcCtD
Butabarbital—Vomiting—Goserelin—breast cancer	0.00119	0.00186	CcSEcCtD
Butabarbital—Constipation—Irinotecan—breast cancer	0.00118	0.00185	CcSEcCtD
Butabarbital—Constipation—Mitoxantrone—breast cancer	0.00118	0.00185	CcSEcCtD
Butabarbital—Rash—Goserelin—breast cancer	0.00118	0.00184	CcSEcCtD
Butabarbital—Hypersensitivity—Thiotepa—breast cancer	0.00118	0.00184	CcSEcCtD
Butabarbital—Dermatitis—Goserelin—breast cancer	0.00118	0.00184	CcSEcCtD
Butabarbital—Somnolence—Fluorouracil—breast cancer	0.00118	0.00184	CcSEcCtD
Butabarbital—Headache—Goserelin—breast cancer	0.00117	0.00183	CcSEcCtD
Butabarbital—Anxiety—Paclitaxel—breast cancer	0.00117	0.00183	CcSEcCtD
Butabarbital—Nausea—Tamoxifen—breast cancer	0.00116	0.00182	CcSEcCtD
Butabarbital—Constipation—Gemcitabine—breast cancer	0.00115	0.0018	CcSEcCtD
Butabarbital—Ataxia—Doxorubicin—breast cancer	0.00114	0.00178	CcSEcCtD
Butabarbital—Nausea—Melphalan—breast cancer	0.00114	0.00178	CcSEcCtD
Butabarbital—Feeling abnormal—Irinotecan—breast cancer	0.00114	0.00178	CcSEcCtD
Butabarbital—Feeling abnormal—Mitoxantrone—breast cancer	0.00114	0.00178	CcSEcCtD
Butabarbital—Confusional state—Paclitaxel—breast cancer	0.00114	0.00178	CcSEcCtD
Butabarbital—Nausea—Goserelin—breast cancer	0.00111	0.00174	CcSEcCtD
Butabarbital—Feeling abnormal—Gemcitabine—breast cancer	0.00111	0.00173	CcSEcCtD
Butabarbital—Shock—Paclitaxel—breast cancer	0.00111	0.00173	CcSEcCtD
Butabarbital—Dizziness—Vinorelbine—breast cancer	0.00111	0.00173	CcSEcCtD
Butabarbital—Body temperature increased—Irinotecan—breast cancer	0.00109	0.00171	CcSEcCtD
Butabarbital—Body temperature increased—Mitoxantrone—breast cancer	0.00109	0.00171	CcSEcCtD
Butabarbital—Feeling abnormal—Fluorouracil—breast cancer	0.00109	0.0017	CcSEcCtD
Butabarbital—Vomiting—Vinorelbine—breast cancer	0.00106	0.00166	CcSEcCtD
Butabarbital—Body temperature increased—Gemcitabine—breast cancer	0.00106	0.00166	CcSEcCtD
Butabarbital—Dizziness—Thiotepa—breast cancer	0.00106	0.00165	CcSEcCtD
Butabarbital—Rash—Vinorelbine—breast cancer	0.00106	0.00165	CcSEcCtD
Butabarbital—Dermatitis—Vinorelbine—breast cancer	0.00105	0.00165	CcSEcCtD
Butabarbital—Hypotension—Paclitaxel—breast cancer	0.00105	0.00165	CcSEcCtD
Butabarbital—Headache—Vinorelbine—breast cancer	0.00105	0.00164	CcSEcCtD
Butabarbital—Syncope—Docetaxel—breast cancer	0.00105	0.00164	CcSEcCtD
Butabarbital—Body temperature increased—Fluorouracil—breast cancer	0.00105	0.00163	CcSEcCtD
Butabarbital—Loss of consciousness—Docetaxel—breast cancer	0.00103	0.00161	CcSEcCtD
Butabarbital—Hypersensitivity—Irinotecan—breast cancer	0.00102	0.00159	CcSEcCtD
Butabarbital—Hypersensitivity—Mitoxantrone—breast cancer	0.00102	0.00159	CcSEcCtD
Butabarbital—Vomiting—Thiotepa—breast cancer	0.00102	0.00159	CcSEcCtD
Butabarbital—Syncope—Capecitabine—breast cancer	0.00102	0.00159	CcSEcCtD
Butabarbital—Rash—Thiotepa—breast cancer	0.00101	0.00158	CcSEcCtD
Butabarbital—Dermatitis—Thiotepa—breast cancer	0.00101	0.00157	CcSEcCtD
Butabarbital—Headache—Thiotepa—breast cancer	0.001	0.00157	CcSEcCtD
Butabarbital—Somnolence—Paclitaxel—breast cancer	0.001	0.00157	CcSEcCtD
Butabarbital—Loss of consciousness—Capecitabine—breast cancer	0.000995	0.00156	CcSEcCtD
Butabarbital—Nausea—Vinorelbine—breast cancer	0.000994	0.00155	CcSEcCtD
Butabarbital—Hypersensitivity—Fluorouracil—breast cancer	0.000974	0.00152	CcSEcCtD
Butabarbital—Constipation—Paclitaxel—breast cancer	0.000963	0.00151	CcSEcCtD
Butabarbital—Confusional state—Docetaxel—breast cancer	0.000962	0.0015	CcSEcCtD
Butabarbital—Anxiety—Capecitabine—breast cancer	0.00096	0.0015	CcSEcCtD
Butabarbital—Nausea—Thiotepa—breast cancer	0.00095	0.00148	CcSEcCtD
Butabarbital—Shock—Docetaxel—breast cancer	0.000939	0.00147	CcSEcCtD
Butabarbital—Confusional state—Capecitabine—breast cancer	0.000932	0.00146	CcSEcCtD
Butabarbital—Feeling abnormal—Paclitaxel—breast cancer	0.000928	0.00145	CcSEcCtD
Butabarbital—Bradycardia—Epirubicin—breast cancer	0.000922	0.00144	CcSEcCtD
Butabarbital—Dizziness—Irinotecan—breast cancer	0.000913	0.00143	CcSEcCtD
Butabarbital—Shock—Capecitabine—breast cancer	0.000909	0.00142	CcSEcCtD
Butabarbital—Hypotension—Docetaxel—breast cancer	0.000892	0.00139	CcSEcCtD
Butabarbital—Body temperature increased—Paclitaxel—breast cancer	0.00089	0.00139	CcSEcCtD
Butabarbital—Vomiting—Mitoxantrone—breast cancer	0.000878	0.00137	CcSEcCtD
Butabarbital—Vomiting—Irinotecan—breast cancer	0.000878	0.00137	CcSEcCtD
Butabarbital—Dizziness—Fluorouracil—breast cancer	0.000874	0.00137	CcSEcCtD
Butabarbital—Rash—Mitoxantrone—breast cancer	0.00087	0.00136	CcSEcCtD
Butabarbital—Rash—Irinotecan—breast cancer	0.00087	0.00136	CcSEcCtD
Butabarbital—Dermatitis—Irinotecan—breast cancer	0.00087	0.00136	CcSEcCtD
Butabarbital—Dermatitis—Mitoxantrone—breast cancer	0.00087	0.00136	CcSEcCtD
Butabarbital—Headache—Mitoxantrone—breast cancer	0.000865	0.00135	CcSEcCtD
Butabarbital—Headache—Irinotecan—breast cancer	0.000865	0.00135	CcSEcCtD
Butabarbital—Hypotension—Capecitabine—breast cancer	0.000863	0.00135	CcSEcCtD
Butabarbital—Vomiting—Gemcitabine—breast cancer	0.000855	0.00134	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—breast cancer	0.000853	0.00133	CcSEcCtD
Butabarbital—Somnolence—Docetaxel—breast cancer	0.000848	0.00133	CcSEcCtD
Butabarbital—Rash—Gemcitabine—breast cancer	0.000848	0.00133	CcSEcCtD
Butabarbital—Dermatitis—Gemcitabine—breast cancer	0.000847	0.00132	CcSEcCtD
Butabarbital—Headache—Gemcitabine—breast cancer	0.000842	0.00132	CcSEcCtD
Butabarbital—Vomiting—Fluorouracil—breast cancer	0.000841	0.00131	CcSEcCtD
Butabarbital—Rash—Fluorouracil—breast cancer	0.000834	0.0013	CcSEcCtD
Butabarbital—Dermatitis—Fluorouracil—breast cancer	0.000833	0.0013	CcSEcCtD
Butabarbital—Hypersensitivity—Paclitaxel—breast cancer	0.000829	0.0013	CcSEcCtD
Butabarbital—Headache—Fluorouracil—breast cancer	0.000828	0.0013	CcSEcCtD
Butabarbital—Nausea—Irinotecan—breast cancer	0.00082	0.00128	CcSEcCtD
Butabarbital—Nausea—Mitoxantrone—breast cancer	0.00082	0.00128	CcSEcCtD
Butabarbital—Constipation—Docetaxel—breast cancer	0.000816	0.00128	CcSEcCtD
Butabarbital—Nausea—Gemcitabine—breast cancer	0.000799	0.00125	CcSEcCtD
Butabarbital—Constipation—Capecitabine—breast cancer	0.00079	0.00124	CcSEcCtD
Butabarbital—Feeling abnormal—Docetaxel—breast cancer	0.000786	0.00123	CcSEcCtD
Butabarbital—Nausea—Fluorouracil—breast cancer	0.000785	0.00123	CcSEcCtD
Butabarbital—Tension—Epirubicin—breast cancer	0.000774	0.00121	CcSEcCtD
Butabarbital—Nervousness—Epirubicin—breast cancer	0.000766	0.0012	CcSEcCtD
Butabarbital—Feeling abnormal—Capecitabine—breast cancer	0.000761	0.00119	CcSEcCtD
Butabarbital—Body temperature increased—Docetaxel—breast cancer	0.000754	0.00118	CcSEcCtD
Butabarbital—Dizziness—Paclitaxel—breast cancer	0.000745	0.00116	CcSEcCtD
Butabarbital—Body temperature increased—Capecitabine—breast cancer	0.00073	0.00114	CcSEcCtD
Butabarbital—Agitation—Epirubicin—breast cancer	0.000725	0.00113	CcSEcCtD
Butabarbital—Tension—Doxorubicin—breast cancer	0.000716	0.00112	CcSEcCtD
Butabarbital—Vomiting—Paclitaxel—breast cancer	0.000716	0.00112	CcSEcCtD
Butabarbital—Thiopental—CYP3A4—breast cancer	0.000714	0.123	CrCbGaD
Butabarbital—Rash—Paclitaxel—breast cancer	0.00071	0.00111	CcSEcCtD
Butabarbital—Dermatitis—Paclitaxel—breast cancer	0.000709	0.00111	CcSEcCtD
Butabarbital—Nervousness—Doxorubicin—breast cancer	0.000709	0.00111	CcSEcCtD
Butabarbital—Syncope—Epirubicin—breast cancer	0.000707	0.00111	CcSEcCtD
Butabarbital—Headache—Paclitaxel—breast cancer	0.000705	0.0011	CcSEcCtD
Butabarbital—Hypersensitivity—Docetaxel—breast cancer	0.000703	0.0011	CcSEcCtD
Butabarbital—Phenobarbital—CYP1A1—breast cancer	0.000695	0.12	CrCbGaD
Butabarbital—Confusional state—Methotrexate—breast cancer	0.000694	0.00108	CcSEcCtD
Butabarbital—Loss of consciousness—Epirubicin—breast cancer	0.000693	0.00108	CcSEcCtD
Butabarbital—Hypersensitivity—Capecitabine—breast cancer	0.000681	0.00106	CcSEcCtD
Butabarbital—Agitation—Doxorubicin—breast cancer	0.000671	0.00105	CcSEcCtD
Butabarbital—Anxiety—Epirubicin—breast cancer	0.000669	0.00105	CcSEcCtD
Butabarbital—Nausea—Paclitaxel—breast cancer	0.000669	0.00105	CcSEcCtD
Butabarbital—Syncope—Doxorubicin—breast cancer	0.000654	0.00102	CcSEcCtD
Butabarbital—Confusional state—Epirubicin—breast cancer	0.000649	0.00101	CcSEcCtD
Butabarbital—Hypotension—Methotrexate—breast cancer	0.000643	0.00101	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—breast cancer	0.000641	0.001	CcSEcCtD
Butabarbital—Shock—Epirubicin—breast cancer	0.000633	0.00099	CcSEcCtD
Butabarbital—Dizziness—Docetaxel—breast cancer	0.000631	0.000987	CcSEcCtD
Butabarbital—Anxiety—Doxorubicin—breast cancer	0.000619	0.000968	CcSEcCtD
Butabarbital—Somnolence—Methotrexate—breast cancer	0.000611	0.000956	CcSEcCtD
Butabarbital—Dizziness—Capecitabine—breast cancer	0.000611	0.000955	CcSEcCtD
Butabarbital—Vomiting—Docetaxel—breast cancer	0.000607	0.000949	CcSEcCtD
Butabarbital—Rash—Docetaxel—breast cancer	0.000602	0.000941	CcSEcCtD
Butabarbital—Hypotension—Epirubicin—breast cancer	0.000601	0.000941	CcSEcCtD
Butabarbital—Dermatitis—Docetaxel—breast cancer	0.000601	0.00094	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—breast cancer	0.000601	0.000939	CcSEcCtD
Butabarbital—Headache—Docetaxel—breast cancer	0.000598	0.000935	CcSEcCtD
Butabarbital—Pentobarbital—CYP3A4—breast cancer	0.000592	0.102	CrCbGaD
Butabarbital—Vomiting—Capecitabine—breast cancer	0.000587	0.000919	CcSEcCtD
Butabarbital—Shock—Doxorubicin—breast cancer	0.000586	0.000916	CcSEcCtD
Butabarbital—Rash—Capecitabine—breast cancer	0.000583	0.000911	CcSEcCtD
Butabarbital—Dermatitis—Capecitabine—breast cancer	0.000582	0.00091	CcSEcCtD
Butabarbital—Headache—Capecitabine—breast cancer	0.000579	0.000905	CcSEcCtD
Butabarbital—Somnolence—Epirubicin—breast cancer	0.000572	0.000895	CcSEcCtD
Butabarbital—Nausea—Docetaxel—breast cancer	0.000567	0.000886	CcSEcCtD
Butabarbital—Feeling abnormal—Methotrexate—breast cancer	0.000567	0.000886	CcSEcCtD
Butabarbital—Hypotension—Doxorubicin—breast cancer	0.000557	0.00087	CcSEcCtD
Butabarbital—Constipation—Epirubicin—breast cancer	0.00055	0.000861	CcSEcCtD
Butabarbital—Nausea—Capecitabine—breast cancer	0.000549	0.000858	CcSEcCtD
Butabarbital—Body temperature increased—Methotrexate—breast cancer	0.000544	0.00085	CcSEcCtD
Butabarbital—Feeling abnormal—Epirubicin—breast cancer	0.00053	0.000829	CcSEcCtD
Butabarbital—Somnolence—Doxorubicin—breast cancer	0.000529	0.000828	CcSEcCtD
Butabarbital—Constipation—Doxorubicin—breast cancer	0.000509	0.000796	CcSEcCtD
Butabarbital—Body temperature increased—Epirubicin—breast cancer	0.000509	0.000796	CcSEcCtD
Butabarbital—Hypersensitivity—Methotrexate—breast cancer	0.000507	0.000792	CcSEcCtD
Butabarbital—Feeling abnormal—Doxorubicin—breast cancer	0.000491	0.000767	CcSEcCtD
Butabarbital—Hypersensitivity—Epirubicin—breast cancer	0.000474	0.000742	CcSEcCtD
Butabarbital—Body temperature increased—Doxorubicin—breast cancer	0.000471	0.000736	CcSEcCtD
Butabarbital—Dizziness—Methotrexate—breast cancer	0.000455	0.000711	CcSEcCtD
Butabarbital—Phenobarbital—CYP3A4—breast cancer	0.000444	0.0767	CrCbGaD
Butabarbital—Hypersensitivity—Doxorubicin—breast cancer	0.000439	0.000686	CcSEcCtD
Butabarbital—Vomiting—Methotrexate—breast cancer	0.000437	0.000684	CcSEcCtD
Butabarbital—Rash—Methotrexate—breast cancer	0.000434	0.000678	CcSEcCtD
Butabarbital—Dermatitis—Methotrexate—breast cancer	0.000433	0.000678	CcSEcCtD
Butabarbital—Headache—Methotrexate—breast cancer	0.000431	0.000674	CcSEcCtD
Butabarbital—Dizziness—Epirubicin—breast cancer	0.000426	0.000666	CcSEcCtD
Butabarbital—Vomiting—Epirubicin—breast cancer	0.000409	0.00064	CcSEcCtD
Butabarbital—Nausea—Methotrexate—breast cancer	0.000409	0.000639	CcSEcCtD
Butabarbital—Rash—Epirubicin—breast cancer	0.000406	0.000635	CcSEcCtD
Butabarbital—Dermatitis—Epirubicin—breast cancer	0.000405	0.000634	CcSEcCtD
Butabarbital—Headache—Epirubicin—breast cancer	0.000403	0.000631	CcSEcCtD
Butabarbital—Dizziness—Doxorubicin—breast cancer	0.000394	0.000616	CcSEcCtD
Butabarbital—Nausea—Epirubicin—breast cancer	0.000382	0.000598	CcSEcCtD
Butabarbital—Vomiting—Doxorubicin—breast cancer	0.000379	0.000592	CcSEcCtD
Butabarbital—Rash—Doxorubicin—breast cancer	0.000376	0.000587	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—breast cancer	0.000375	0.000587	CcSEcCtD
Butabarbital—Headache—Doxorubicin—breast cancer	0.000373	0.000583	CcSEcCtD
Butabarbital—Phenobarbital—ABCB1—breast cancer	0.000369	0.0638	CrCbGaD
Butabarbital—Nausea—Doxorubicin—breast cancer	0.000354	0.000553	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—STAT5A—breast cancer	0.000273	0.00357	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—NCOA1—breast cancer	0.000273	0.00357	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000273	0.00356	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000273	0.00356	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000273	0.00356	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—BCHE—breast cancer	0.000271	0.00353	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—BCHE—breast cancer	0.00027	0.00353	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—PIK3CA—breast cancer	0.00027	0.00353	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—AR—breast cancer	0.000267	0.00349	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—PLG—breast cancer	0.000266	0.00348	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—BCHE—breast cancer	0.000262	0.00342	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—COMT—breast cancer	0.000257	0.00335	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000253	0.0033	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000249	0.00325	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000249	0.00325	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—BCHE—breast cancer	0.000246	0.00322	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000242	0.00315	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.00024	0.00313	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SPP1—breast cancer	0.000239	0.00312	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000239	0.00312	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—NCOA1—breast cancer	0.000239	0.00312	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000238	0.00311	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—ACHE—breast cancer	0.000238	0.0031	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HES1—breast cancer	0.000235	0.00307	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ACHE—breast cancer	0.000233	0.00304	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—PLG—breast cancer	0.000233	0.00304	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ACHE—breast cancer	0.000231	0.00301	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—COX11—breast cancer	0.000226	0.00295	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000226	0.00295	CbGpPWpGaD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—breast cancer	0.000225	0.00294	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000218	0.00285	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000218	0.00284	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000218	0.00284	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—COMT—breast cancer	0.000216	0.00283	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—COMT—breast cancer	0.000216	0.00282	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ACHE—breast cancer	0.000213	0.00278	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—COMT—breast cancer	0.00021	0.00273	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000209	0.00273	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—BCHE—breast cancer	0.000207	0.0027	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—COX11—breast cancer	0.000207	0.0027	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000207	0.0027	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000207	0.0027	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—BCHE—breast cancer	0.000203	0.00265	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000201	0.00262	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—BCHE—breast cancer	0.000201	0.00262	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.0002	0.00261	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000199	0.0026	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000199	0.0026	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000197	0.00257	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NFKBIA—breast cancer	0.000197	0.00257	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—COMT—breast cancer	0.000197	0.00257	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—APC—breast cancer	0.000191	0.00249	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000189	0.00247	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000187	0.00245	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ACHE—breast cancer	0.000186	0.00243	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—BCHE—breast cancer	0.000186	0.00242	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000183	0.00239	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000183	0.00239	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000182	0.00238	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—FOS—breast cancer	0.000182	0.00237	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000182	0.00237	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000182	0.00237	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—COX11—breast cancer	0.000181	0.00236	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000181	0.00236	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—BRAF—breast cancer	0.00018	0.00235	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ACHE—breast cancer	0.000179	0.00233	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000178	0.00232	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000175	0.00229	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000171	0.00223	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AR—breast cancer	0.000166	0.00216	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—COMT—breast cancer	0.000166	0.00216	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000165	0.00216	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—breast cancer	0.000164	0.00214	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ACHE—breast cancer	0.000163	0.00213	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—COMT—breast cancer	0.000162	0.00212	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—BCHE—breast cancer	0.000162	0.00212	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—COMT—breast cancer	0.000161	0.0021	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000159	0.00208	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000159	0.00208	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000157	0.00205	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000157	0.00204	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000157	0.00204	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—BCHE—breast cancer	0.000156	0.00203	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000154	0.00201	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000153	0.002	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—breast cancer	0.000151	0.00197	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—RAF1—breast cancer	0.000151	0.00197	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—breast cancer	0.00015	0.00196	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—breast cancer	0.00015	0.00196	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RAF1—breast cancer	0.00015	0.00195	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RELA—breast cancer	0.000149	0.00195	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000149	0.00195	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000149	0.00194	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—COMT—breast cancer	0.000148	0.00194	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MTOR—breast cancer	0.000146	0.00191	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—breast cancer	0.000146	0.0019	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000146	0.0019	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HES1—breast cancer	0.000146	0.0019	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000145	0.00189	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000143	0.00187	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ACHE—breast cancer	0.000143	0.00186	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—BCHE—breast cancer	0.000142	0.00186	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—BRAF—breast cancer	0.000138	0.0018	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—BRAF—breast cancer	0.000138	0.0018	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000138	0.0018	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—breast cancer	0.000137	0.00179	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—breast cancer	0.000137	0.00179	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000137	0.00179	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—breast cancer	0.000135	0.00176	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—breast cancer	0.000134	0.00175	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000133	0.00174	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—JUN—breast cancer	0.000131	0.00171	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—COMT—breast cancer	0.00013	0.00169	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CTNNB1—breast cancer	0.00013	0.00169	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000128	0.00167	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000127	0.00166	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000126	0.00164	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—BRAF—breast cancer	0.000126	0.00164	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000125	0.00163	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—BCHE—breast cancer	0.000124	0.00162	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—COMT—breast cancer	0.000124	0.00162	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000124	0.00162	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK8—breast cancer	0.000124	0.00161	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000123	0.0016	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000122	0.0016	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000122	0.00159	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—breast cancer	0.000119	0.00155	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000118	0.00154	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SRC—breast cancer	0.000117	0.00153	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000116	0.00152	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MDM2—breast cancer	0.000116	0.00151	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—breast cancer	0.000116	0.00151	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000115	0.00151	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—RAF1—breast cancer	0.000115	0.00151	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—RAF1—breast cancer	0.000115	0.0015	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000115	0.0015	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—COMT—breast cancer	0.000114	0.00148	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000113	0.00148	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—STAT3—breast cancer	0.000113	0.00147	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—breast cancer	0.000112	0.00146	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—breast cancer	0.000112	0.00146	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	0.00011	0.00144	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.00011	0.00144	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—breast cancer	0.000109	0.00142	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK3—breast cancer	0.000108	0.00141	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—BRAF—breast cancer	0.000106	0.00138	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000106	0.00138	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MDM2—breast cancer	0.000105	0.00137	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000105	0.00137	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—RAF1—breast cancer	0.000105	0.00137	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000104	0.00136	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—BRAF—breast cancer	0.000104	0.00135	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000103	0.00134	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—BRAF—breast cancer	0.000102	0.00134	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—RAF1—breast cancer	0.000102	0.00134	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000101	0.00132	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	0.0001	0.00131	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—COMT—breast cancer	9.94e-05	0.0013	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TUBB3—breast cancer	9.9e-05	0.00129	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—BRAF—breast cancer	9.48e-05	0.00124	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A2—breast cancer	9.42e-05	0.00123	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—RAF1—breast cancer	9.36e-05	0.00122	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCG2—breast cancer	9.23e-05	0.0012	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	9.23e-05	0.0012	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	9.2e-05	0.0012	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TFRC—breast cancer	9e-05	0.00117	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—breast cancer	8.9e-05	0.00116	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MDM2—breast cancer	8.85e-05	0.00116	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—RAF1—breast cancer	8.82e-05	0.00115	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—breast cancer	8.81e-05	0.00115	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MDM2—breast cancer	8.68e-05	0.00113	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NCOA2—breast cancer	8.66e-05	0.00113	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—RAF1—breast cancer	8.65e-05	0.00113	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MDM2—breast cancer	8.59e-05	0.00112	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—RAF1—breast cancer	8.56e-05	0.00112	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.44e-05	0.0011	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—HRAS—breast cancer	8.29e-05	0.00108	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—BRAF—breast cancer	8.28e-05	0.00108	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.26e-05	0.00108	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—HRAS—breast cancer	8.25e-05	0.00108	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A2—breast cancer	8.24e-05	0.00107	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TFRC—breast cancer	8.23e-05	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—RAF1—breast cancer	8.18e-05	0.00107	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.18e-05	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCG2—breast cancer	8.07e-05	0.00105	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.98e-05	0.00104	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MDM2—breast cancer	7.94e-05	0.00104	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—BRAF—breast cancer	7.94e-05	0.00104	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NCOA2—breast cancer	7.92e-05	0.00103	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—breast cancer	7.91e-05	0.00103	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—RAF1—breast cancer	7.91e-05	0.00103	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—breast cancer	7.59e-05	0.000991	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—breast cancer	7.58e-05	0.000989	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.55e-05	0.000986	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—breast cancer	7.54e-05	0.000985	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—JUN—breast cancer	7.36e-05	0.00096	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	7.3e-05	0.000953	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.3e-05	0.000952	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NCOA1—breast cancer	7.3e-05	0.000952	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—breast cancer	7.28e-05	0.00095	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—BRAF—breast cancer	7.26e-05	0.000947	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TFRC—breast cancer	7.19e-05	0.000938	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—breast cancer	7.18e-05	0.000937	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PLG—breast cancer	7.11e-05	0.000928	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—breast cancer	6.94e-05	0.000906	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.92e-05	0.000903	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—RAF1—breast cancer	6.92e-05	0.000902	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NCOA1—breast cancer	6.67e-05	0.000871	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MDM2—breast cancer	6.65e-05	0.000868	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—RAF1—breast cancer	6.63e-05	0.000865	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.6e-05	0.000862	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—breast cancer	6.56e-05	0.000856	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PLG—breast cancer	6.5e-05	0.000849	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—breast cancer	6.43e-05	0.000839	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.38e-05	0.000832	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—HRAS—breast cancer	6.35e-05	0.000829	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—BRAF—breast cancer	6.35e-05	0.000828	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—HRAS—breast cancer	6.34e-05	0.000828	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.34e-05	0.000827	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—breast cancer	6.3e-05	0.000822	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—breast cancer	6.15e-05	0.000803	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MDM2—breast cancer	6.08e-05	0.000794	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—RAF1—breast cancer	6.06e-05	0.000791	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—breast cancer	6e-05	0.000783	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.83e-05	0.000761	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	5.79e-05	0.000756	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—HRAS—breast cancer	5.78e-05	0.000754	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—breast cancer	5.76e-05	0.000752	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PLG—breast cancer	5.68e-05	0.000742	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—breast cancer	5.51e-05	0.000719	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MDM2—breast cancer	5.32e-05	0.000694	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—RAF1—breast cancer	5.3e-05	0.000691	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.25e-05	0.000685	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	5.07e-05	0.000661	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—breast cancer	5.04e-05	0.000657	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—HRAS—breast cancer	4.86e-05	0.000634	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—HRAS—breast cancer	4.76e-05	0.000622	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—HRAS—breast cancer	4.71e-05	0.000615	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—breast cancer	4.45e-05	0.00058	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—HRAS—breast cancer	4.36e-05	0.000569	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—breast cancer	3.94e-05	0.000514	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—HRAS—breast cancer	3.81e-05	0.000497	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—HRAS—breast cancer	3.65e-05	0.000476	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	3.6e-05	0.00047	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—RAF1—breast cancer	3.56e-05	0.000465	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—HRAS—breast cancer	3.34e-05	0.000436	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	3.26e-05	0.000425	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	3.15e-05	0.000411	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—HRAS—breast cancer	2.92e-05	0.000381	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	2.85e-05	0.000372	CbGpPWpGaD
